New York, NY -- (SBWIRE) -- 12/15/2017 -- In a new report titled 'Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,' Persistence Market Research analyzes the global non-melanoma skin cancer treatment market over an eight year forecast period 2017 – 2025 and throws light on the various factors impacting revenue growth of the market over the said period. The report highlights the market forecasts for the different segments and presents deeper insights for informed decision making.
North America is estimated to hold a market share of roughly 55% in the global non-melanoma skin cancer treatment market in 2017 and is anticipated to have the highest attractiveness index of 3.0 during the forecast period. Non-melanoma skin cancer is more prevalent in senior citizens and the Population Reference Bureau estimates that Americans over the age of 65 will double to almost 100 million by 2060.
Radiation therapy is larger than chemotherapy and photodynamic therapy combined, making it imperative for key stakeholders in the non-melanoma skin cancer treatment market to focus on this treatment type. Radiation therapy is poised to be worth more than US$ 4.7 Bn by end 2025. Within radiation therapy, companies may wish to target superficial radiation therapy.
Even though squamous cell carcinoma is predicted to record a higher CAGR of 6.4% from 2017-2025, it is unlikely to outpace basal cell carcinoma anytime soon as the latter is likely to value at approx. thrice the size of the former by end 2025. The attractiveness index of basal cell carcinoma is 1.5, considerably larger than the 0.5 of squamous cell carcinoma during the same period.
The treatment modalities for non-melanoma skin cancer usually require expensive radiation therapy. Therefore, hospitals are preferred over ambulatory surgical centers and specialty clinics in the non-melanoma skin cancer treatment market. The hospital segment is expected to reach a value of US$ 2 Bn in 2017 itself.
Request A Sample Report@ https://www.persistencemarketresearch.com/samples/3648
Summary of Table of Content
1. Executive Summary
2. Market Introduction
3. Non-Melanoma Skin Cancer Treatment Market Opportunity Analysis
4. North America Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
5. Latin America Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
6. Europe Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
7. Asia Pacific Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
8. Middle East & Africa Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
9. Competition Landscape
10. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region
11. Global Non-Melanoma Skin Cancer Treatment Analysis 2012–2016 and Forecast 2017–2025, By Treatment Type
12. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Indication
13. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By End User
14. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
15. Assumptions and Acronyms Used
16. Research Methodology
Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/non-melanoma-skin-cancer-market/toc
About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.